-
Accelr8 Technology Corp. (NYSE-A:AXK), Denver, Colo. Denver Health & Hospital Authority, Denver, Colo. Business: Diagnostic, Infectious Accelr8 and Denver Health received notice that the U.S. Department of Defense's …
Published on 5/21/2012
-
AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Boehringer Ingelheim GmbH, Ingelheim, Germany GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Merck KGaA (Xetra:…
Published on 5/21/2012
-
Dendreon Corp. (NASDAQ:DNDN), Seattle, Wash. Business: Cancer Dendreon disclosed in a 10Q filing that the SEC is investigating the company. Dendreon said it does not know the specific focus of the investigation, but …
Published on 5/21/2012
-
Fibrocell Science Inc. (OTCBB:FCSC), Exton, Pa. Business: Dermatology, Neurology Fibrocell announced the formation of the Clinical Investigations for Dermal Mesenchymally-Obtained Derivatives (CIDMOD) Initiative to …
Published on 5/21/2012
-
Medtronic Inc. (NYSE:MDT), Minneapolis, Minn. Business: Musculoskeletal Medtronic said it received notice from the U.S. Department of Justice and the Office of the U.S. Attorney for the District of Massachusetts that …
Published on 5/21/2012
-
Merck KGaA (Xetra:MRK), Darmstadt, Germany Business: Pharmaceuticals Merck hopes to achieve 300 million ($386.6 million) in net cost savings by 2014 through the previously announced restructuring of its Merck Serono …
Published on 5/21/2012
-
Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. Business: Neurology Abbott will pay $1.5 billion to federal and state authorities to resolve criminal and civil liability regarding past marketing activities for …
Published on 5/14/2012
-
Actelion Ltd. (SIX:ATLN), Allschwil, Switzerland Business: Pharmaceuticals Actelion said it plans to reduce R&D and overhead spending by refocusing R&D activities on specialty areas and out-licensing its primary care …
Published on 5/14/2012
-
AMAG Pharmaceuticals Inc. (NASDAQ:AMAG), Lexington, Mass. Business: Hematology Chairman Michael Narachi said it was time to shift AMAG's focus away from a potential sale of the company in order to grow sales of anemia …
Published on 5/14/2012
-
Angel Biotechnology Holdings plc (LSE:ABH), Edinburgh, U.K. Business: Supply/Service Angel Biotechnology launched its new subsidiary Angel Biomedical Ltd., which acquired assets from an undisclosed biomaterial and …
Published on 5/14/2012
-
Ark Therapeutics Group plc (LSE:AKT), London, U.K. University College London, London, U.K. Business: Endocrine/Metabolic Ark said that a consortium led by the college received a six-year grant of up to 6 million ($7.9 …
Published on 5/14/2012
-
Bio-Matrix Scientific Group Inc. (OTCQB:BMSN; Pink:PMSN), La Mesa, Calif. Business: Gene/Cell therapy Bio-Matrix said it established subsidiary Regen BioPharma Inc. to develop stem cell therapies. Regen also secured $20…
Published on 5/14/2012
-
Biolex Therapeutics Inc., Pittsboro, N.C. Business: Infectious Biolex said it is seeking to sell worldwide rights to its remaining asset, hepatitis candidate Locteron. The controlled-release formulation of recombinant …
Published on 5/14/2012
-
Catalent Pharma Solutions Inc., Somerset, N.J. Profectus BioSciences Inc., Baltimore, Md. Business: Infectious, Biomanufacturing Profectus said it received a $5.6 million grant from NIH's National Institute of Allergy …
Published on 5/14/2012
-
China Nuokang Bio-Pharmaceutical Inc. (NASDAQ:NKBP), Shenyang, China Business: Hematology, Cardiovascular China Nuokang's board received a preliminary, non-binding proposal from the company's CEO and Chairman Baizhong …
Published on 5/14/2012
-
Helicos BioSciences Corp. (Pink:HLCS), Cambridge, Mass. Pacific Biosciences of California Inc. (NASDAQ:PACB), Menlo Park, Calif. Business: Genomics Pacific Biosciences said it and Helicos settled a 2010 suit in the U.S.…
Published on 5/14/2012
-
Innovative Medicines Initiative (IMI), Brussels, Belgium Juvenile Diabetes Research Foundation International (JDRF), New York, N.Y. Business: Endocrine/Metabolic The EU's public-private Innovative Medicines Initiative …
Published on 5/14/2012
-
Isogenica Ltd., Little Chesterford, U.K. Business: High throughput screening Isogenica said it received a three-year, 700,000 ($911,190) grant under the European Commission's Framework Programme 7 (FP7). The company …
Published on 5/14/2012
-
Kineta Inc., Seattle, Wash. University of Washington, Seattle, Wash. University of Texas Medical Branch, Galveston, Texas Business: Infectious The NIH's National Institute of Allergy and Infectious Diseases (NIAID) …
Published on 5/14/2012
-
Prophylix Pharma A/S, Tromso, Norway Business: Hematology Prophylix said PROFNAIT, a consortium led by the company, will receive a grant of up to 6 million ($7.8 million) from the European Commission's Framework …
Published on 5/14/2012
-
Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN), Venlo, the Netherlands Bill & Melinda Gates Foundation, Seattle, Wash. Grand Challenges Canada, Toronto, Ontario Business: Diagnostic Qiagen joined the Point-of-Care Diagnostics …
Published on 5/14/2012
-
Repligen Corp. (NASDAQ:RGEN), Waltham, Mass. Business: Diagnostic Repligen recommended stockholders vote for an amended stockholder proposal submitted by Ronald Chez to increase the proposed threshold necessary for …
Published on 5/14/2012
-
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Gastrointestinal Takeda submitted a new request for reconsideration to the Osaka Regional Tax Bureau (ORTB) in which the company requested the bureau …
Published on 5/14/2012
-
Aerocrine AB (SSE:AERO) Solna, Sweden Business: Diagnostic The U.S. Bankruptcy Court for the Northern District of California awarded Aerocrine $1.3 million to resolve patent infringement claims against now-defunct …
Published on 5/7/2012
-
BGI, Shenzhen, China George Mason University, Fairfax, Va. Massachusetts Eye and Ear Infirmary, Boston, Mass. University of Oklahoma, Norman, Okla. Business: Genomics BGI partnered with George Mason University, the …
Published on 5/7/2012